-
Views
-
Cite
Cite
Khang Luu, Zhe Shao, Herbert Schwarz, The relevance of soluble CD137 in the regulation of immune responses and for immunotherapeutic intervention, Journal of Leukocyte Biology, Volume 107, Issue 5, May 2020, Pages 731–738, https://doi.org/10.1002/JLB.2MR1119-224R
- Share Icon Share
Abstract
CD137 is a potent costimulatory receptor. Several agonistic anti-CD137 antibodies are currently in clinical trials for tumor immunotherapy. Soluble forms of CD137 (sCD137) are generated by differential splicing and antagonize the activities of membrane-bound CD137 (mCD137) and of therapeutic CD137 agonists. sCD137 is found in sera of patients suffering from autoimmune diseases where it is a natural regulator of immune responses, and which has therapeutic potential for immune-mediated diseases. This review summarizes the current knowledge on sCD137, highlights its potential role in immunotherapy against cancer and in autoimmune diseases, and presents important issues to be addressed by future research.